ICM
PATH icon

Invenomic Capital Management’s UiPath PATH Stock Holding History

Invenomic Capital Management’s Portfolio PATH Stock Details PATH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.2M Buy
1,636,902
+973,468
+147% +$12.4M 0.83% 46
2025
Q4 		$10.9M Sell
663,434
-434,705
-40% -$6.77M 0.51% 66
2025
Q3 		$14.7M Buy
+1,098,139
New +$13M 0.71% 49
2025
Q2 		– Sell
-528,839
Closed -$5.45M – 184
2025
Q1 		$5.45M Buy
528,839
+168,690
+47% +$2.17M 0.28% 109
2024
Q4 		$4.58M Buy
360,149
+5,027
+1% +$66.4K 0.22% 113
2024
Q3 		$4.55M Buy
+355,122
New +$4.35M 0.25% 105

Other funds holding PATH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Invenomic Capital Management's PATH Position: Q1 2026 in Review

Invenomic Capital Management increased its UiPath (PATH) stake by 147% in Q1 2026, buying an estimated $12.4M and bringing the position to 1,636,902 shares worth $18.2M. The position accounts for 0.83% of the portfolio, ranked #46.

Invenomic Capital Management first reported a position in PATH in Q3 2024 and has held it in 6 quarters since. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Invenomic Capital Management held 1,636,902 shares of UiPath worth $18.2M as of Q1 2026.
  • Invenomic Capital Management bought 973,468 UiPath shares in Q1 2026, an estimated $12.4M.
  • UiPath made up 0.83% of Invenomic Capital Management's portfolio in Q1 2026, its #46 holding.
  • Invenomic Capital Management first reported a position in UiPath in Q3 2024 and has held it in 6 quarters since.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.